Innovative Pharmaceutical Biotech (HKSE:00399) Short-Term Debt : HK$793.96 Mil (As of Sep. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Short-Term Debt?

Innovative Pharmaceutical Biotech's Short-Term Debt for the quarter that ended in Sep. 2024 was HK$793.96 Mil.

Innovative Pharmaceutical Biotech's quarterly Short-Term Debt increased from Sep. 2023 (HK$324.59 Mil) to Mar. 2024 (HK$336.46 Mil) and increased from Mar. 2024 (HK$336.46 Mil) to Sep. 2024 (HK$793.96 Mil).

Innovative Pharmaceutical Biotech's annual Short-Term Debt increased from Mar. 2022 (HK$40.00 Mil) to Mar. 2023 (HK$1,093.32 Mil) but then declined from Mar. 2023 (HK$1,093.32 Mil) to Mar. 2024 (HK$336.46 Mil).

Innovative Pharmaceutical Biotech Short-Term Debt Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Short-Term Debt Chart

Innovative Pharmaceutical Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

7.00

746.53

40.00

1,093.32

336.46

Innovative Pharmaceutical Biotech Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															765.58	1,093.32	324.59	336.46	793.96

Innovative Pharmaceutical Biotech Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Innovative Pharmaceutical Biotech Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovative Pharmaceutical Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG

Website

http://www.ipb.asia

Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.

Executives

Mao Yumin	2101 Beneficial owner
Chau Yiu Ting	2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin	2101 Beneficial owner
Chau Yiu Ting	2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines